Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study
- Abderrahim Oulhaj
- , Ahmed R. Alsuwaidi
- , Abubaker Suliman
- , Huda Gasmelseed
- , Shaima Khan
- , Shamma Alawi
- , Yaman Hukan
- , Junu George
- , Fayez Alshamsi
- , Farrukh Sheikh
- , Zahir Osman Eltahir Babiker
- , Juergen Prattes
- , Harald Sourij
Research output: Contribution to journal › Article › peer-review
28
Link opens in a new tab
Citations
(Scopus)